<DOC>
	<DOCNO>NCT00001298</DOCNO>
	<brief_summary>High dose methotrexate leucovorin rescue demonstrate activity numerous malignancy . Although high dose methotrexate generally well tolerate , unpredictable life-threatening toxicity occur . For patient markedly delay clearance methotrexate secondary renal dysfunction , therapeutic option limit efficacy . Carboxypeptidase-G2 inactivates methotrexate hydrolyze C-terminal glutamate residue . Carboxypeptidase-G2 could use rescue patient renal dysfunction delay methotrexate excretion , provide alternative renal clearance route elimination .</brief_summary>
	<brief_title>A Trial Carboxypeptidase-G2 ( CPDG2 ) Thymidine Management Patients With Methotrexate Toxicity Renal Dysfunction</brief_title>
	<detailed_description>High dose methotrexate leucovorin rescue demonstrate activity numerous malignancy . Although high dose methotrexate generally well tolerate , unpredictable life-threatening toxicity occur . For patient markedly delay clearance methotrexate secondary renal dysfunction , therapeutic option limit efficacy . Carboxypeptidase-G2 inactivates methotrexate hydrolyze C-terminal glutamate residue . Carboxypeptidase-G2 could use rescue patient renal dysfunction delay methotrexate excretion , provide alternative renal clearance route elimination .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Patients age risk lifethreatening toxicity follow MTX administration secondary delay drug excretion define : Plasma MTX concentration least 10 micromoles/liter 42 hour start MTX infusion ; OR Creatinine least 1.5 time upper limit normal creatinine clearance le 60 ml/sqm/min delay MTX excretion document plasma MTX concentration measurement ( least 2 standard deviation mean ) least 12 hour follow MTX administration .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2000</verification_date>
	<keyword>Antibody</keyword>
	<keyword>DAMPA</keyword>
	<keyword>Enzyme</keyword>
	<keyword>Kidney</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Thymidine</keyword>
	<keyword>Toxicity</keyword>
</DOC>